GLP-1 receptor agonists are reshaping obesity care. OHE highlights access challenges, prescribing policy, and how patient and ...

Professor Graham Cookson responds to President Donald Trump's Executive Order on drug prices published earlier this week.

Long-acting therapies offer value for chronic disease, improving adherence and outcomes. This OHE report highlights HTA gaps, ...

Dimitrios is an economist and his research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D. In addition, he is interested ...

The National Institute for Health and Care Excellence (NICE) is the body responsible for recommending medicines for use within the National Health Service (NHS) in England. High Proportion of ...

Health Technology Assessment (HTA) agencies evaluate and make decisions on the use, funding, or reimbursement of health technologies based on clinical and economic evidence. Economic evaluations can ...

Oriol has built a career in the planning, policy and decision-making environment, participating not just in the micro management, but also being deeply involved on the meso and macro policy areas.

OHE Graduate School actively supports and invests in the development of future health economists, underscoring our dedication to advancing evidence-based health policy. As part of our commitment to ...

Kelsey joined OHE in March 2025 as an External Engagement Officer. She holds a BA degree in Psychology from the University of Chicago and an MSc Public Health (Health Promotion) from the London School ...